We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+7.74%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$4.88B
AUM Growth
-$338M
Cap. Flow
-$638M
Cap. Flow %
-13.08%
Top 10 Hldgs %
41.5%
Holding
103
New
20
Increased
15
Reduced
27
Closed
26

Top Buys

Rank Stock Value
1
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$248M
2
ELN
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
+$141M
3
DELL
DELL INC
DELL
+$136M
4
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$129M
5
MSFT icon
Microsoft
MSFT
+$125M

Top Sells

Rank Stock Value
1
NWSA
NEWS CORPORATION CL-A
NWSA
+$302M
2
YHOO
Yahoo Inc
YHOO
+$267M
3
SFD
SMITHFIELD FOODS,INC
SFD
+$165M
4
AZO icon
AutoZone
AZO
+$144M
5
BKNG icon
Booking.com
BKNG
+$132M

Sector Composition

Rank Sector Weight
1 Communication Services 13.19%
2 Industrials 11.39%
3 Healthcare 10.25%
4 Real Estate 10.23%
5 Consumer Discretionary 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EDU icon
51
New Oriental
EDU
$8.88B
$12.4M 0.26%
+500,000
New +$11.4M
GWPH
52
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$10.1M 0.21%
584,000
+24,000
+4% +$276K
AMGN icon
53
Amgen
AMGN
$238B
$9.85M 0.2%
+88,000
New +$9.54M
PCO
54
DELISTED
Pendrell Corporation - Class A
PCO
$7.75M 0.16%
3,997
– –
RUE
55
DELISTED
RUE21 INC COM STK (DE)
RUE
$7.46M 0.15%
+185,000
New +$7.66M
HZNP
56
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$7.45M 0.15%
2,223,071
– –
CIM
57
Chimera Investment
CIM
$964M
$7.01M 0.14%
153,667
– –
PACT
58
DELISTED
PACTERA TECHNOLOGY INTL LTD SPONSORED ADR
PACT
$6.83M 0.14%
+1,160,000
New +$7.72M
HCBK
59
DELISTED
HUDSON CITY BANCORP INC
HCBK
$6.8M 0.14%
+751,907
New +$7.09M
NKTR icon
60
Nektar Therapeutics
NKTR
$2.53B
$6.38M 0.13%
+40,667
New +$7.52M
OREX
61
DELISTED
Orexigen Therapeutics, Inc.
OREX
$5.83M 0.12%
95,000
– –
LNCO
62
DELISTED
LINNCO LLC COM SHS REPSTG LTD LIABILITY
LNCO
$5.73M 0.12%
+196,500
New +$5.7M
TTM
63
DELISTED
Tata Motors Limited
TTM
$5.26M 0.11%
197,514
– –
ANAC
64
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$4.78M 0.1%
450,000
-187,500
-29% -$1.64M
PBY
65
DELISTED
PEP BOYS MANNY MOE& JACK
PBY
$4.75M 0.1%
380,495
-355,315
-48% -$4.3M
JCP
66
DELISTED
J.C. Penney Company, Inc.
JCP
$4.41M 0.09%
+500,000
New +$7.13M
VIRX
67
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.55M 0.07%
3,405
+1,143
+51% +$1.22M
ARQL
68
DELISTED
Arqule Inc
ARQL
$3.41M 0.07%
1,464,699
– –
HK
69
DELISTED
Halcon Resources Corporation
HK
$3.28M 0.07%
4,292
-10,062
-70% -$9.17M
MACK
70
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$3.06M 0.06%
102,356
-33,328
-25% -$1.17M
STML
71
DELISTED
Stemline Therapeutics, Inc.
STML
$2.67M 0.05%
59,000
-76,000
-56% -$2.48M
ZTS icon
72
Zoetis
ZTS
$32.1B
$1.69M 0.03%
54,179
-98,100
-64% -$3.01M
FBIO icon
73
Fortress Biotech
FBIO
$95.7M
$824K 0.02%
7,828
– –
ASIA
74
DELISTED
ASIAINFO-LINKAGE INC COM STK (DE)
ASIA
$319K 0.01%
+27,662
New +$320K
OPK icon
75
Opko Health
OPK
$1.1B
$284K 0.01%
+32,246
New +$259K
1 2
3
4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2013 Portfolio in Review

As of Q3 2013, Thomas Steyer held 103 positions worth $4.88B, down 6.5% from $5.22B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Thomas Steyer withdrew a net $638M in Q3 2013, closing 26 positions and reducing 27 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $302M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 13% of assets, up from 9.9% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Thomas Steyer opened a new position in Twenty-First Century Fox, Inc. Class A worth $138M.

  • Thomas Steyer's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 4,105,000 shares worth $138M.
  • Thomas Steyer added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $248M increase.
  • Thomas Steyer's biggest Q3 2013 reduction was Yahoo Inc, cutting an estimated $267M.
  • Thomas Steyer fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $302M.
  • Thomas Steyer's ten largest holdings make up 42% of its $4.88B portfolio in Q3 2013.
  • Thomas Steyer opened 20 new positions and closed 26 in Q3 2013.
  • Thomas Steyer's portfolio value fell 6.5% quarter-over-quarter to $4.88B.

Based on Farallon Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.